Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EFS Auvergne-Rhône-Alpes is the regional division of the Établissement Français du Sang, the national public agency responsible for blood transfusion services in France. The organization manages the entire blood supply chain within the region, including collection, testing, processing, and distribution to healthcare facilities. Beyond blood banking, it operates as a major center for cell and tissue therapy, featuring state-of-the-art GMP manufacturing facilities for advanced therapy medicinal products (ATMPs). EFS Auvergne-Rhône-Alpes is heavily involved in clinical research, particularly in the fields of hematology, immunology, and regenerative medicine. It provides specialized medical services such as HLA typing and immunogenetics to support organ and bone marrow transplantation. The entity plays a critical role in the French healthcare ecosystem by ensuring the availability of life-saving labile blood products and advancing innovative cell-based treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EFS Auvergne-Rhône-Alpes.